Chromatographically purified vancomycin: Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria

L. S. Wang, C. Y. Liu, F. D. Wang, C. P. Fung, Z. H. Chiu, D. L. Cheng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Fourteen patients with serious infections caused by Staphylococcus aureus and other gram-positive bacteria were prospectively treated with chromatographically purified vancomycin in an open-label, nonrandomized study, between December 1986 and June 1987. Five patients were excluded from the evaluation of efficacy. Among the nine evaluable patients, cure was achieved in six patients - a success rate of 67%. One patient had a relapse of osteomyelitis, and cultures of draining pus were positive for oxacillin-resistant S aureus within three weeks after the discontinuation of vancomycin therapy. One patient failed to respond to vancomycin therapy for S aureus - induced endocarditis, meningitis, and osteomyelitis; in another patient, the treatment failed to reverse the course of S aureus septicemia. No serious drug toxicity, for example, nephrotoxicity, was encountered in any patient. One patient (7%) experienced mild ototoxicity. Four patients (29%) had mild phlebitis, two patients (14%) had a transiently positive Coombs' test, and one patient (7%) had a 'red neck syndrome' and 'pain and spasm syndrome'. Chromatographically purified vancomycin is an effective antibiotic in the treatment of serious infections caused by susceptible gram-positive bacteria. Some minor side effects of vancomycin may not be due to impurities in the preparation but rather to the vancomycin itself.

Original languageEnglish
Pages (from-to)574-584
Number of pages11
JournalClinical Therapeutics
Volume10
Issue number5
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Gram-Positive Bacteria
Vancomycin
Staphylococcus aureus
Infection
Therapeutics
Osteomyelitis
Coombs Test
Phlebitis
Oxacillin
Suppuration
Neck Pain
Spasm
Endocarditis
Drug-Related Side Effects and Adverse Reactions
Meningitis
Sepsis
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Pharmacology

Cite this

Wang, L. S., Liu, C. Y., Wang, F. D., Fung, C. P., Chiu, Z. H., & Cheng, D. L. (1988). Chromatographically purified vancomycin: Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria. Clinical Therapeutics, 10(5), 574-584.

Chromatographically purified vancomycin : Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria. / Wang, L. S.; Liu, C. Y.; Wang, F. D.; Fung, C. P.; Chiu, Z. H.; Cheng, D. L.

In: Clinical Therapeutics, Vol. 10, No. 5, 1988, p. 574-584.

Research output: Contribution to journalArticle

Wang, L. S. ; Liu, C. Y. ; Wang, F. D. ; Fung, C. P. ; Chiu, Z. H. ; Cheng, D. L. / Chromatographically purified vancomycin : Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria. In: Clinical Therapeutics. 1988 ; Vol. 10, No. 5. pp. 574-584.
@article{37cda8d6ed2648349adcc846dc870a77,
title = "Chromatographically purified vancomycin: Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria",
abstract = "Fourteen patients with serious infections caused by Staphylococcus aureus and other gram-positive bacteria were prospectively treated with chromatographically purified vancomycin in an open-label, nonrandomized study, between December 1986 and June 1987. Five patients were excluded from the evaluation of efficacy. Among the nine evaluable patients, cure was achieved in six patients - a success rate of 67{\%}. One patient had a relapse of osteomyelitis, and cultures of draining pus were positive for oxacillin-resistant S aureus within three weeks after the discontinuation of vancomycin therapy. One patient failed to respond to vancomycin therapy for S aureus - induced endocarditis, meningitis, and osteomyelitis; in another patient, the treatment failed to reverse the course of S aureus septicemia. No serious drug toxicity, for example, nephrotoxicity, was encountered in any patient. One patient (7{\%}) experienced mild ototoxicity. Four patients (29{\%}) had mild phlebitis, two patients (14{\%}) had a transiently positive Coombs' test, and one patient (7{\%}) had a 'red neck syndrome' and 'pain and spasm syndrome'. Chromatographically purified vancomycin is an effective antibiotic in the treatment of serious infections caused by susceptible gram-positive bacteria. Some minor side effects of vancomycin may not be due to impurities in the preparation but rather to the vancomycin itself.",
author = "Wang, {L. S.} and Liu, {C. Y.} and Wang, {F. D.} and Fung, {C. P.} and Chiu, {Z. H.} and Cheng, {D. L.}",
year = "1988",
language = "English",
volume = "10",
pages = "574--584",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "5",

}

TY - JOUR

T1 - Chromatographically purified vancomycin

T2 - Therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria

AU - Wang, L. S.

AU - Liu, C. Y.

AU - Wang, F. D.

AU - Fung, C. P.

AU - Chiu, Z. H.

AU - Cheng, D. L.

PY - 1988

Y1 - 1988

N2 - Fourteen patients with serious infections caused by Staphylococcus aureus and other gram-positive bacteria were prospectively treated with chromatographically purified vancomycin in an open-label, nonrandomized study, between December 1986 and June 1987. Five patients were excluded from the evaluation of efficacy. Among the nine evaluable patients, cure was achieved in six patients - a success rate of 67%. One patient had a relapse of osteomyelitis, and cultures of draining pus were positive for oxacillin-resistant S aureus within three weeks after the discontinuation of vancomycin therapy. One patient failed to respond to vancomycin therapy for S aureus - induced endocarditis, meningitis, and osteomyelitis; in another patient, the treatment failed to reverse the course of S aureus septicemia. No serious drug toxicity, for example, nephrotoxicity, was encountered in any patient. One patient (7%) experienced mild ototoxicity. Four patients (29%) had mild phlebitis, two patients (14%) had a transiently positive Coombs' test, and one patient (7%) had a 'red neck syndrome' and 'pain and spasm syndrome'. Chromatographically purified vancomycin is an effective antibiotic in the treatment of serious infections caused by susceptible gram-positive bacteria. Some minor side effects of vancomycin may not be due to impurities in the preparation but rather to the vancomycin itself.

AB - Fourteen patients with serious infections caused by Staphylococcus aureus and other gram-positive bacteria were prospectively treated with chromatographically purified vancomycin in an open-label, nonrandomized study, between December 1986 and June 1987. Five patients were excluded from the evaluation of efficacy. Among the nine evaluable patients, cure was achieved in six patients - a success rate of 67%. One patient had a relapse of osteomyelitis, and cultures of draining pus were positive for oxacillin-resistant S aureus within three weeks after the discontinuation of vancomycin therapy. One patient failed to respond to vancomycin therapy for S aureus - induced endocarditis, meningitis, and osteomyelitis; in another patient, the treatment failed to reverse the course of S aureus septicemia. No serious drug toxicity, for example, nephrotoxicity, was encountered in any patient. One patient (7%) experienced mild ototoxicity. Four patients (29%) had mild phlebitis, two patients (14%) had a transiently positive Coombs' test, and one patient (7%) had a 'red neck syndrome' and 'pain and spasm syndrome'. Chromatographically purified vancomycin is an effective antibiotic in the treatment of serious infections caused by susceptible gram-positive bacteria. Some minor side effects of vancomycin may not be due to impurities in the preparation but rather to the vancomycin itself.

UR - http://www.scopus.com/inward/record.url?scp=0023695313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023695313&partnerID=8YFLogxK

M3 - Article

C2 - 2856600

AN - SCOPUS:0023695313

VL - 10

SP - 574

EP - 584

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 5

ER -